For the Inventor, By the Inventor

Enter assignee name

London, United Kingdom

The Institute of Cancer Research

USPTO Granted Patents = 24

CIPO Patents = 2

EPO Patents = 8

Forward Citations = 119

Loading Chart...

Loading Chart...

50 inventors (with patents filed for the assignee):

Martin James Drysdale (11 out of 18 patents)

Brian William Dymock (11 out of 20 patents)

Edward McDonald (8 out of 22 patents)

4. Kwai Ming Cheung (7 out of 9 patents)

5. Karen Elizabeth James (6 out of 6 patents)

6. Thomas Peter Matthews (6 out of 14 patents)

7. Harry Finch (6 out of 6 patents)

8. Paul Webb (6 out of 14 patents)

9. Martin O Leach (3 out of 6 patents)

10. Gavin George Poludniowski (2 out of 2 patents)

11. Michael David Ross Thomas (2 out of 2 patents)

12. Christofe Fromont (2 out of 2 patents)

13. Xavier Barril-Alonso (2 out of 3 patents)

14. Mandy Christine Beswick (2 out of 5 patents)

15. Michael Khazen (2 out of 3 patents)

24 patents: Sort by Forward Citations

1. 12110286 - Benzimidazolone derived inhibitors of BCL6 (2024-10-08),

2. 11234987 - Isoxazole compounds as inhibitors of heat shock proteins (2022-02-01),

3. 10413550 - Isoxazole compounds as inhibitors of heat shock proteins (2019-09-17),

4. 9718793 - Isoxazole compounds as inhibitors of heat shock proteins (2017-08-01),

5. 8705696 - Radiotherapy system (2014-04-22),

6. 8642594 - Substituted thieno[2,3-d]pyrimidines as HSP90 inhibitors (2014-02-04),

7. 8507480 - Isoxazole compounds as inhibitors of heat shock proteins (2013-08-13),

8. 8460166 - Radiotherapy planning and delivery (2013-06-11),

9. 8450310 - Isoxazole compounds as inhibitors of heat shock proteins (2013-05-28),

10. 8306189 - X-ray apparatus (2012-11-06),

11. 8238518 - Radiotherapy system (2012-08-07),

12. 8143241 - DNA damage repair inhibitors for treatment of cancer (2012-03-27),

13. 7916909 - Method and means for image processing (2011-03-29),

14. 7820658 - Substituted thieno[2,3-d]pyrimidines as HSP90 inhibitors (2010-10-26),

15. 7803831 - 3-(2-hydroxy-phenyl)-1H-pyrazole-4-carboxylic acid amide derivatives as HSP90 inhibitors for the treatment of cancer (2010-09-28),

The Institute of Cancer Research is one of the leading research institutes specializing in cancer studies and treatments. We are dedicated to discovering new insights into cancer biology and developing innovative therapies to combat various types of cancer. Our multidisciplinary approach involves collaboration between scientists, clinicians, and patients to accelerate the translation of research findings into clinical practice. Visit our website to learn more about our groundbreaking research and impact in the field of cancer.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

24 Patents

#131 in London

#735 in United Kingdom

#25,875 in the World

London, United Kingdom

The Institute of Cancer Research

Forward Citations = 119

50 inventors:

Martin James Drysdale (11 out of 18 patents)

Brian William Dymock (11 out of 20 patents)

Edward McDonald (8 out of 22 patents)

4. Kwai Ming Cheung (7 out of 9 patents)

5. Karen Elizabeth James (6 out of 6 patents)

Please report any incorrect information to support@idiyas.com

Loading…